Humans roamed the aisles, robots performed at booths, and the future of automation was on full display in Chicago.
Zacks Investment Research on MSN
UiPath vs. Nu Holdings: Which disruptive growth stock is a buy?
Both Nu Holdings NU and UiPath Inc. PATH are technology-driven disruptors transforming large industries through software.
After months of runaway corporate usage, enterprise buyers are starting to treat AI as a budget problem as much as a ...
Not every process needs an agent. Kuber Sharma of UiPath makes the case that the next phase of enterprise AI is about ...
Zacks Investment Research on MSN
Why UiPath (PATH) is a top growth stock for the long term
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
UiPath is delivering accelerating revenue growth and rising ARR, benefiting from the broader AI-driven business transformation. Despite a strong Q1 beat-and-raise, PATH shares remain down ~30% YTD, ...
Capital Impact sold 2,753,724 shares of UiPath last quarter. The quarter-end position value decreased by $47.43 million, reflecting the combined effect of trading and market price changes. Meanwhile, ...
Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.
NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leader in agentic business orchestration, today announced the release of agentic AI capabilities on UiPath Automation Suite™. The Automation Suite ...
The street-high consensus price target of $17.0 implies 63.9% upside potential for the stock, making UiPath, Inc. (NYSE:PATH) one of the 10 best robotics stocks to buy under $30. On April 27, 2026, ...
The integration promises to provide faster decision-making, better operational efficiency and scaled AI adoption, as well as aiding in turning data into measurable business outcomes. Data quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results